Treating thrombosis in neonates with LMWH.
ثبت نشده
چکیده
Low molecular weight heparin (LMWH) might be an alternative to established treatment for deep vein thrombosis in neonates, London researchers report.
منابع مشابه
Neonatal renal venous and arterial thrombosis
Renal vein thrombosis (RVT) is one of the more common forms of neonatal thrombosis accounting for 15-20% of systemic thromboembolism[1,2]. A median age at presentation of 2-3 days have been reported [1,3], with unilateral and bilateral involvement of renal vein in 89-72% and 28-11% of cases, respectively[4,5]. The clinical presentation of RVT consists of increased kidney size, macroor microhema...
متن کاملAntithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
This chapter about antithrombotic therapy in neonates and children is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Grade 1 recommendations are strong and indicate that the benefits do, or do not, outweigh risks, burden, and costs, and Grade 2 suggests that individual patient values may lead t...
متن کاملConjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent.
BACKGROUND Heparin administration is usually limited to intravenous or subcutaneous injection. Oral delivery of heparin is an alternative to this and has been in great demand for treating patients who are at a high risk of deep vein thrombosis or pulmonary embolism. In this study, new heparin derivatives were synthesized to enhance the oral absorption of heparin in the gastrointestinal tract. M...
متن کاملLow molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: A systematic review and meta-analysis
INTRODUCTION There are two main choices of anti-coagulation in cerebral venous thrombosis: Unfractionated heparin versus low molecular weight heparin. A consensus is yet to be reached regarding which agent is optimal. Therefore the aim of this systematic review and meta-analysis was to identify which agent is most effective in treating CVT. METHODS Databases Pubmed (MEDLINE), Google Scholar a...
متن کاملHeparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model.
Low molecular weight heparin (LMWH) is being tested as an experimental drug for improving pregnancy outcome in women with inherited thrombophilia and placenta-mediated pregnancy complications, such as recurrent pregnancy loss. The role of thrombotic processes in these disorders remains unproven, and the issue of antithrombotic prophylaxis is intensely debated. Using a murine model of factor V L...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Nursing standard (Royal College of Nursing (Great Britain) : 1987)
دوره 10 15 شماره
صفحات -
تاریخ انتشار 1996